Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protean PTEN: form and function.

Kristin A Waite1, Charis Eng

  • 1Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, 420 West 12th Avenue, Columbus, OH 43210, USA.

American Journal of Human Genetics
|March 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors.

Endocrine-related cancer·2023
Same author

A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.

Annals of surgical oncology·2023
Same author

Development of webcam-collected and artificial-intelligence-derived social and cognitive performance measures for neurodevelopmental genetic syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics·2023
Same author

Hemizygous variants in protein phosphatase 1 regulatory subunit 3F (PPP1R3F) are associated with a neurodevelopmental disorder characterized by developmental delay, intellectual disability and autistic features.

Human molecular genetics·2023
Same author

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.

Breast cancer research and treatment·2023
Same author

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome.

NPJ genomic medicine·2023
Same journal

Bi-allelic missense variants in human GPN2 result in Perrault syndrome.

American journal of human genetics·2026
Same journal

Integrative analysis of gastric tissue transcriptomes and gastric cancer GWAS implicates candidate susceptibility genes.

American journal of human genetics·2026
Same journal

A transparent and generalizable deep-learning framework for genomic ancestry prediction.

American journal of human genetics·2026
Same journal

Data-driven RNA phenotyping captures genetically regulated dimensions of the transcriptome.

American journal of human genetics·2026
Same journal

Linkage disequilibrium and allelic heterogeneity explain variation in coronary artery disease risk at 9p21 across populations and reduced effect in Africans.

American journal of human genetics·2026
Same journal

Genome-wide association study and predictors of neonatal blood cell traits in Hispanic newborns.

American journal of human genetics·2026
See all related articles

Germline mutations in the PTEN gene cause PTEN hamartoma tumor syndromes, including Cowden syndrome. These mutations affect both lipid and protein phosphatase activities, impacting cell growth and survival pathways.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Germline mutations in the PTEN tumor-suppressor gene are associated with a spectrum of disorders known as PTEN hamartoma tumor syndromes (PHTS).
  • PHTS includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, and related conditions, characterized by hamartomas and increased cancer risk.
  • The PTEN gene encodes a dual-specificity protein and lipid phosphatase crucial for regulating cell growth and survival.

Purpose of the Study:

  • To review the phenotypic spectrum associated with germline PTEN mutations.
  • To highlight the functional significance of PTEN's lipid and protein phosphatase activities in disease pathogenesis.
  • To emphasize the role of the PI3K/AKT and MAPK pathways in PTEN-mediated growth regulation.

Main Methods:

Related Experiment Videos

  • Literature review of studies on PTEN mutations and associated syndromes.
  • Analysis of PTEN's enzymatic activities (lipid and protein phosphatase).
  • Discussion of signaling pathways regulated by PTEN, including PI3K/AKT and MAPK.

Main Results:

  • Germline PTEN mutations lead to a diverse range of phenotypes, underscoring its role as a tumor suppressor.
  • Exon 5 is identified as a mutation hotspot, likely due to the protein's core functional motif.
  • PTEN's lipid phosphatase activity regulates the PI3K/AKT pathway, mediating growth suppression.
  • PTEN's protein phosphatase activity influences cell survival pathways like MAPK, also contributing to growth arrest.

Conclusions:

  • PTEN mutations are central to PHTS, with varied clinical presentations.
  • Both lipid and protein phosphatase activities of PTEN are critical for its tumor-suppressive functions.
  • Understanding PTEN's dual enzymatic roles provides insights into PHTS pathogenesis and potential therapeutic strategies.